NEW YORK, April 29-Applied Biosystems and HTS Biosystems will work together to develop and commercialize a new functional proteomics system, the two companies said today.
In this collaboration, the two companies will work to improve HTS Biosystems' FLEX CHIP, which uses surface plasmon resonance technology to reveal protein binding kinetics. The system is being developed to permit high throughput, label-free protein identification. A few early versions have been placed with HTS collaborators.
ABI, which owns 18 percent of HTS, did not disclose financial details of the arrangement.
The collaboration will "capitalize on Applied Biosystems' expertise in instrument systems development, manufacturing and marketing, and HTS Biosystems' proprietary technology and system integration," said ABI vice president Lauren Linton in a statement.
HTS has established similar collaborations with Mitsubishi Chemical, Protein Sciences Corporation, and others. The company is based in Hopkinton, Mass.
To see the company press release, click here.